The global topical scar treatment market size was estimated at USD 1.69 billion in 2024 and is expected to grow at a CAGR of 11.9% from 2025 to 2030. The market is expected to grow due to several factors, such as the growing concern among people regarding their aesthetic appearance, the increasing number of road accidents and burn injuries, and technological advancements supplementing new device launches. According to a survey published by the NIH in July 2022, involving 11,100 participants from Brazil, China, France, and the U.S., 48.5% of respondents reported having at least one scar. Among these individuals, 22% noted that their most recent scar was less than a year old, indicating a significant demand for recent scar treatment options.
The first two waves of the COVID-19 pandemic were marked by the rapid adoption of telemedicine in all domains of the healthcare sector. Skincare, being non-emergency, requires minimal hospital visits. Even though final procedures require a patient to visit the hospital or doctor’s office, pre-planning and post-procedure management were largely preferred through telemedicine.
Topical products refer to various substances, compounds, or formulations that are applied to the surface of the skin, hair, or nails for various purposes. These products are designed to have localized effects on the area of application and are commonly used in skincare, haircare, and other personal care routines. A model was determined by analyzing the prevalence of scars for each region and country. It was seen that most of the patients sought topical treatment for scar management. The adoption rate of creams vs. gels vs. silicon sheets vs. others was then analyzed. In addition, average product prices, usability, and treatment duration were considered for determining the market size and assigning the segment split for each product type.
Advancements in technology and innovation are driving growth in the industry, with a strong focus on natural-based treatments and multifunctional products. Innovations have led to the development of effective, gentle formulations that incorporate natural ingredients such as aloe vera, onion extract, vitamin E, and centella asiatica (often known as "cica"), which are well-known for their scar-reducing and skin-soothing properties. For instance, in September 2024, Dr. Speron's Natural Skin Care, LLC, introduced an innovative product designed to make a meaningful difference for individuals dealing with the physical and emotional impact of scars from injuries, surgeries, and skin conditions. These natural-based treatments appeal to consumers seeking safe, skin-friendly options with fewer synthetic chemicals.treatment products are also extensively used.
The growing number of road accidents is one of the high-impact rendering factors, raising the demand for scar treatment products. According to the Population Reference Bureau, around 50 million people are injured due to road accidents every year, which frequently leads to scars requiring surgical treatment. In addition, patients who undergo such surgeries develop surgical scars and are provided topical products to improve & reduce their appearance. Hence, the rising number of road accidents and the increasing number of cosmetic surgeries are expected to propel the need for topical products for scar treatment.
The industry is highly innovative. New treatments leverage bioactive compounds, silicone-based gels, and nanotechnology to enhance skin healing and reduce scar visibility. Laser-assisted delivery systems and peptide-based therapies also improve treatment efficacy, addressing a wider range of scar types. With rising demand for minimally invasive solutions, these innovations are making scar treatment more effective and accessible to consumers worldwide. For instance, in January 2023, Skinuva proudly announced the launch of its latest product, Skinuva Scar+ SPF 30, a physician-developed solution designed to set new standards in skincare. Committed to advancing skincare with science-backed, clinically-tested formulations, Skinuva introduced this scar photoaging defense cream, which combines highly selective growth factors with a mineral-based Zinc Oxide sunscreen to protect and improve scar appearance.
The industry is experiencing a high level of mergers and acquisitions as companies seek to expand their portfolios and leverage advanced technologies. Key players are acquiring specialized firms to access innovative formulations and proprietary technologies, such as silicone-based and bioactive treatments. This consolidation enhances market reach, accelerates product development, and strengthens competitive positioning as firms aim to address the increasing global demand for effective, non-invasive scar treatment solutions.
The regulatory framework significantly impacts the industry, shaping product approvals, safety standards, and market entry timelines. Stringent regulations from bodies like the FDA and EMA ensure product efficacy and safety, requiring rigorous clinical trials and compliance with quality standards. This process can extend development timelines and increase costs but ultimately boost consumer trust. Regulatory harmonization and streamlined processes are crucial for faster innovation and expanding global market access for scar treatments.
Product expansion is a key trend in the market, with companies introducing diverse formulations to meet varying consumer needs. New products target different scar types, such as acne, keloids, and surgical scars, using ingredients like silicone, antioxidants, and bioactive peptides. Advanced delivery mechanisms, such as sprays and patches, improve convenience and effectiveness. This expansion helps brands cater to broader demographics, supporting market growth and addressing increasing consumer demand for specialized scar solutions.
The market is witnessing substantial growth through country expansion, especially in emerging markets across Asia-Pacific, Latin America, and the Middle East. Companies are targeting these regions due to rising disposable incomes, increased awareness of scar management, and demand for non-invasive treatments. Strategic partnerships and localized product offerings help brands navigate regulatory requirements and cultural preferences, enabling faster market penetration and growth. This geographic expansion broadens consumer access to advanced scar treatments worldwide.
The creams segment dominated the market, accounting for a share of 36.09% in 2024. Topical creams have specific vitamins and other skincare ingredients that help reduce a scar's appearance. Topical creams are available as OTC products; however, these OTC creams have minimal active ingredients required for adequate treatment. Therefore, patients can be prescribed skincare products specifically designed for their requirements and contain a higher proportion of the active ingredient. For instance, doctors typically prescribe imiquimod cream to people with keloids post-surgical removal.
Silicon sheets are anticipated to witness the fastest growth over the forecast period, owing to their property to make scars less noticeable. Silicone gel sheets are widely used for treating hypertrophic and keloid scars. They are a low-cost, noninvasive treatment to dull and flatten scarring. These are available with self-drying technology and dry within 4 to 5 minutes. According to NCBI, silicone gel sheets can effectively reduce 86% texture, 84% of color, and 68% height of the scars. For instance, CICA-CARE, a silicone gel sheet manufactured by Smith & Nephew, is up to 90% effective in reducing dark, red, or raised scars. The company reported that this product has been used by more than 1 million patients worldwide, including for scars as old as 20 years.
Atrophic scars dominated the market with a revenue share of 37.15% in 2024 and are anticipated to witness the fastest growth over the forecast period due to the rising prevalence of acne scars. The keloid and hypertrophic scars are expected to grow significantly over the forecast period due to the prevalence among people with wound injuries. Atrophic scars are commonly caused by muscle and fat loss in the body over an injured area. Atrophic scars form when the skin does not produce enough collagen to heal the infection site. This type of scar looks like a pit and is typically caused by staphylococcus infections, acne, chickenpox, and surgery. Treating such scars typically entails the application of topical gels, creams, and ointments that are widely available. The scar treatment stimulates the skin's natural healing process by replacing collagen, elastin, and other fibrous tissues. This allows the healed lesion's surface to grow around the surrounding area, as most such scars result from acne; using these creams reduces the visibility of the scars. As the demand for aesthetic appeal grows, the need for topical products to treat atrophic scars also increases.
The market for hypertrophic and keloid scar treatments is seeing significant growth, driven by a high prevalence of these scars among burn and surgical patients, as well as individuals with certain genetic backgrounds. According to a February 2023 NIH report, hypertrophic scarring is particularly prevalent among adult burn patients, with rates ranging from 32% to 72%. Factors associated with higher hypertrophic scar risks include darker skin tones, younger age, female gender, and burns covering more than 20% of the body, especially on the neck and upper limbs. Nearly 75% of burn patients with hypertrophic scars also report neuropathic pain, often exacerbated by scar thickness, pigmentation, vascularity, and hyperplasia.
Retail pharmacies dominated the market with a revenue share of 40.30% in 2024, driven by government support and industry consolidation, which enhances efficiency and cost-effectiveness. This consolidation allows retail pharmacies to offer competitive prices, improve accessibility, and increase service options like health screenings and immunizations, all of which support continued market growth. Government support for pharmacy services further promotes access to essential medications, contributing to the sector's resilience and expansion.
The online distribution channel is projected to witness the fastest growth over the forecast, driven by the increasing consumer preference for convenience and easy access to a wide array of products. E-commerce platforms provide consumers with the opportunity to browse various scar treatment options, compare prices, read product reviews, and make informed decisions-all from the comfort of their own homes. This convenience, coupled with features like doorstep delivery, has made online shopping especially appealing for those seeking non-prescription scar treatments such as creams, gels, and silicone-based products.
North America topical scar treatment market is experiencing steady growth, driven by increased demand for effective, minimally invasive options to reduce scarring from surgeries, injuries, and dermatological issues. Rising awareness around aesthetics and the availability of advanced topical treatments, such as silicone-based gels and creams, are key factors boosting market demand. Concurrently, research in this field focuses on innovative products like bioengineered skin substitutes and advanced wound-healing compounds to improve outcomes. There's also a significant shift toward natural treatments, with consumers showing interest in plant-based ingredients and herbal formulations known for fewer side effects and added skin health benefits
The topical scar treatment market in the U.S. held the largest share of 79.98% in 2024, in the North American region, owing to the high demand for advanced laser scar treatment instruments. The American Burn Association (ABA) reports that there are 486,000 burn cases each year. Scar treatment for burn injuries is covered by government reimbursement policies in the U.S. Scar treatment for acne may not be reimbursed unless a healthcare professional provides a Letter of medical necessity. Patients' increased healthcare spending is another major driver in the U.S. market.
The topical scar treatment market in Europe is experiencing growth, driven by the increasing availability of scar treatments through online platforms. This trend has made scar care products more accessible, particularly as consumers seek convenient, at-home options. For instance, in September 2021, Sonoma Pharmaceuticals, Inc., a leader in healthcare products based on stabilized hypochlorous acid (HOCl), launched Regenacyn Advanced Scar Gel over-the-counter on Amazon.com, as well as MucoClyns on Amazon sites across Europe. Both products, formulated with Sonoma’s patented Microcyn technology, are available for direct consumer orders, expanding access to clinically backed, professional-grade scar treatments.
The UK topical scar treatment market is growing, largely due to the prevalence of injuries from accidents and burns, which frequently result in scarring. In 2022, 0.21% of the UK population was involved in car accidents, resulting in 143,326 accident-related injuries, according to the Department for Transport’s Annual Report. Road collisions in Great Britain led to 29,742 casualties classified as killed or seriously injured (KSI). Interestingly, although motorways account for a fifth of all road traffic, they reported fewer casualties, highlighting a higher collision risk on urban and rural roads compared to motorways.
The topical scar treatment market in Germany is experiencing steady growth, driven by rising consumer awareness about scar care and an increasing demand for non-invasive treatments. Advanced products, including silicone-based gels and creams with natural extracts, are popular due to their efficacy and minimal side effects. Supportive healthcare infrastructure and high-quality standards further boost market expansion and product innovation in Germany.
France topical scar treatment market is expanding, largely due to the prevalence of injuries resulting from road accidents, which frequently lead to scarring. Key players in the French scar treatment market include HRA Pharma, which has established a significant presence in this region. Known for their focus on dermatological solutions, HRA Pharma and other major companies are expanding their market reach in response to rising demand for scar management products. The French market is seeing growth due to both innovations in scar treatments-such as products that combine therapeutic and cosmetic benefits-and increasing consumer awareness of available solutions.
The topical scar treatment market in Asia Pacific is witnessing robust growth, driven by rising demand for innovative and effective scar management solutions. Increasing awareness of scar treatments and advancements in dermatology and wound care are propelling market expansion. Key players in the region are actively investing in R&D to develop advanced formulations like silicone-based products, creams, and gels that provide improved efficacy and patient comfort.
China topical scar treatment market is growing rapidly, driven largely by a rise in acne-related scarring. A September 2022 study in Dermatology and Venereology highlighted that approximately 7.1% of Chinese adolescents suffer from acne scars, with acne typically emerging after the age of 13. Among affected individuals, multiple types of atrophic scars may appear, while hypertrophic scars and keloids are more prevalent in darker-skinned individuals, particularly on the trunk and jawline. This increasing prevalence of acne scars has heightened the demand for effective topical treatments, including silicone-based gels and scar creams.
The topical scar treatment market in Japan is experiencing significant growth, supported by a rise in surgical procedures, including laparoscopic surgeries, which often leave scarring that requires effective management. Among the available treatments, silicone gel sheets have shown considerable promise in scar reduction.
The topical scar treatment market in Latin America is experiencing considerable growth, driven by increasing beauty consciousness, rising cosmetic surgeries, and greater access to online distribution. As consumers in the region become more focused on skin health and aesthetics, the demand for effective scar treatment solutions is expanding. The growing popularity of cosmetic surgeries, such as facelifts, liposuction, and tummy tucks, has contributed to the rising number of scars that require treatment.
Brazil topical scar treatment market is experiencing robust growth, driven by increasing beauty consciousness, a rise in acne scars, and scarring resulting from accidents. As Brazilian consumers place a high value on aesthetics, there is a growing demand for effective solutions to reduce and treat scars, particularly acne scars. The rise in cosmetic awareness and skincare routines is further propelling the market for topical scar treatments.
The topical scar treatment market in the Middle East and Africa (MEA) is experiencing notable growth, driven by rising beauty consciousness, increased demand for natural ingredients, and the expansion of e-commerce platforms. As consumers in the region become more aware of skincare and aesthetic treatments, the demand for practical solutions to treat scars, including acne and post-surgery scars, is growing. The focus on beauty and skincare in countries like the UAE, Saudi Arabia, and South Africa is fueling market expansion, with many seeking non-invasive treatments to improve skin appearance
Saudi Arabia topical scar treatment market is growing rapidly due to the high prevalence of acne scars and increased interest in skincare. The Saudi government actively supports advancements in healthcare, including dermatological research, fostering innovation in scar treatment solutions. Investments in research and technology are leading to the development of new, effective treatments that target acne scars, including products with natural ingredients that align with consumer preferences for gentle, effective solutions.
The major companies in the market are focusing on strategies such as the launch of new products, mergers and acquisitions, and geographical expansions to cater to the unmet demand of the target population. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion to serve the unmet needs of their customers.
The following are the leading companies in the topical scar treatment market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the Topical Scar Treatment Market
In September 2024, researchers at Chulalongkorn University developed an innovative "Transfersome Gel" designed to treat hypertrophic scars and dark spots. Formulated with a key compound derived from the Indian pennywort plant.
In January 2023, Skinuva proudly announced the launch of its latest product, Skinuva Scar+ SPF 30, a physician-developed solution designed to set new standards in skincare. Committed to advancing skincare with science-backed, clinically-tested formulations, Skinuva introduced this scar photoaging defense cream, which combines highly selective growth factors with a mineral-based Zinc Oxide sunscreen to protect and improve scar appearance.
In March 2023, Solution for Scars introduced a scientifically proven formula featuring a natural active ingredient designed to visibly reduce the appearance of symptomatic scars. Developed by a renowned UK plastic surgeon, this cream is a must-have addition to any first-aid kit.
Report Attribute |
Details |
Market size value in 2025 |
USD 1.88 billion |
Revenue forecast in 2030 |
USD 3.31 billion |
Growth rate |
CAGR of 11.9% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Market representation |
Revenue in USD million/billion & CAGR from 2025 to 2030 |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, trends |
Segments covered |
Product, scar type, distribution channel, region |
Country Scope |
U.S.; Canada; Germany; UK.; France; Italy; Spain; Denmark; Sweden; Norway; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Smith & Nephew PLC; Lumenis; Merz Pharmaceuticals, LLC; Sonoma Pharmaceuticals, Inc.; Cynosure; CCA Industries, Inc.; Newmedical Technology Inc.; Mölnlycke Health Care AB; Suneva Medical; Scar Heal inc.; Pacific World Corporation; Perrigo Company plc; Enaltus LLC |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global topical scar treatment market report based on product, scar type, distribution channel, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Creams
Gels
Silicon Sheets
Others
Scar Type Outlook (Revenue, USD Million, 2018 - 2030)
Atrophic Scars
Hypertrophic & Keloid Scars
Contracture Scars
Stretch Marks
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hospital Pharmacies
Retail Pharmacies
Online
Hypermarkets/ Supermarkets
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
France
Italy
Denmark
Norway
Sweden
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global topical scar treatment market size was estimated at USD 1.69 billion in 2024 and is expected to reach USD 1.88 billion in 2025.
b. The global topical scar treatment market is expected to grow at a compound annual growth rate of 11.9% from 2025 to 2030 to reach USD 3.31 billion by 2030.
b. Asia-Pacific dominated the market with a revenue share of 44.5% in 2024 owing to the high aesthetic consciousness among people and the rapid adoption of advanced products. The increasing prevalence of burn injuries, skin-related disorders, and trauma is a major factor likely to contribute to market growth in this region.
b. Some key players operating in the topical scar treatment market include Smith & Nephew PLC; Lumenis; Merz Pharmaceuticals, LLC; Sonoma Pharmaceuticals, Inc.; Cynosure; CCA Industries, Inc.; Newmedical Technology Inc.; Mölnlycke Health Care AB; Suneva Medical.
b. The market is expected to grow due to several factors, such as the growing concern among people regarding their aesthetic appearance, the increasing number of road accidents and burn injuries, and technological advancements supplementing new device launches.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."